DRUGSwww.epgonline.orgDISEASE KNOWLEDGE CENTRESwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgMEDICAL NEWSwww.epgonline.orgLINKSwww.epgonline.org
Members Login
How to use the
Email

Password



EPG News Feed Medical News
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Frequent Searches:
Search
Languages

Browse Other Languages
YouTube - Featured Content

Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here

epgonline.org is not responsible for content on any 3rd party website

Men's Health - understanding, management, diagnosis and treatment information Benign prostatic hyperplasia (BPH) - understanding, management, diagnosis and treatment information Parkinson's Disease - understanding, management, diagnosis and treatment information. Medical conferences for the Healthcare professional
Are you a Doctor or Healthcare Professional? Authorise Viewing

Please register to access disease diagnosis, patient management, physician tools.

By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: United Kingdom

A  |  B  |  C  |  D  |  E  |  F  |  G  |  H  |  I  |  J  |  K  |  L  |  M
N  |  O  |  P  |  Q  |  R  |  S  |  T  |  U  |  V  |  W  |  X  |  Y  |  Z

Medicine information : RENNIE DUO
 
Drug class description :  Reflux suppressants.
Generic Name :  Calcium carbonate, magnesium carbonate, sodium alginate
Drug description :  Oral suspension.
Presentation :  Suspension, calcium carbonate 1200mg, magnesium carbonate 140mg, sodium alginate 300mg per 10mL dose.
Indications :  Symptomatic treatment of complaints resulting from gastro- oesophageal reflux and hyperacidity, such as regurgitation and heartburn.
Adult Dosage :  10mL to be taken one hour after meals and before going to bed. In the case of heartburn between doses, an extra dose of 10mL can be taken. Maximum eight unit doses in 24 hours.
Child Dosage :  Under 12 years, not recommended.
Contra Indications :  Severe renal insufficiency, hypercalcaemia and pre-existing hypophosphataemia. Nephrolithiasis associated with calcium-containing stones. calcium-containing stones. Hypersensitivity to any of the ingredients.
Special Precautions :  Avoid prolonged use. If the symptoms persist or abate only partially, further medical examination is required. As with other antacids, RennieR Duo can mask the symptoms of a gastric malignancy. Impaired renal function - monitor plasma calcium and magnesium levels. Long-term use at high doses can result in hypercalcaemia, magnesaemia and milk-alkali syndrome, especially in patients with renal insufficiency. Prolonged use possibly enhances the risk for the development of renal calculi. 10 mL of suspension contain 120 mg of sodium which should be considered for patients on a restricted sodium diet.
Interactions :  Antibiotics (such as tetracyclines and quinolones), phosphates. Because of possible changes in the rates of absorption on concurrently administered medicines, it is recommended that antacids should not be taken concurrently with these medicines, but 1 to 2 hours later.
Adverse Reactions :  Hypermagnesaemia or hypercalcaemia and alkalosis, especially in patients with impaired renal function, after prolonged use of high does.
Free registration to access disease diagnosis, patient management, physician tools.

Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.

Already Registered?

Please log-in now using our member login box.

Not a member?

Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.

Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.

As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!

REGISTER today it only takes a minute! and it's FREE

Having problems?

Use our forgotten password facility or email us at: contact@epgonline.org

What's New!
Try EPG Mobile
Latest News
Disease Knowledge Centres

EPG Survey Become a member of
the new EPG Survey Panel.
Your opinions matter, get paid for them! Join Now!